Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.
Identifieur interne : 000591 ( Main/Exploration ); précédent : 000590; suivant : 000592Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.
Auteurs : Titilayo Oluyomi-Obi [Canada] ; Lisa Avery [Canada] ; Carol Schneider [Canada] ; Anand Kumar [Canada] ; Stephen Lapinsky [Canada] ; Savas Menticoglou [Canada] ; Ryan Zarychanski [Canada]Source :
- Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [ 1701-2163 ] ; 2010.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Antiviraux (usage thérapeutique), Avortement spontané, Complications de la grossesse et maladies infectieuses (), Femelle, Flambées de maladies, Grippe humaine (), Grossesse, Humains, Maladie grave, Manitoba, Naissance prématurée, Oséltamivir (usage thérapeutique), Sous-type H1N1 du virus de la grippe A, Unités de soins intensifs, Ventilation artificielle.
- MESH :
- usage thérapeutique : Antiviraux, Oséltamivir.
- Adolescent, Adulte, Avortement spontané, Complications de la grossesse et maladies infectieuses, Femelle, Flambées de maladies, Grippe humaine, Grossesse, Humains, Maladie grave, Manitoba, Naissance prématurée, Sous-type H1N1 du virus de la grippe A, Unités de soins intensifs, Ventilation artificielle.
English descriptors
- KwdEn :
- Abortion, Spontaneous, Adolescent, Adult, Antiviral Agents (therapeutic use), Critical Illness, Disease Outbreaks, Female, Humans, Influenza A Virus, H1N1 Subtype, Influenza, Human (complications), Influenza, Human (therapy), Intensive Care Units, Manitoba, Oseltamivir (therapeutic use), Pregnancy, Pregnancy Complications, Infectious (therapy), Premature Birth, Respiration, Artificial.
- MESH :
- chemical , therapeutic use : Antiviral Agents, Oseltamivir.
- geographic : Manitoba.
- complications : Influenza, Human.
- therapy : Influenza, Human, Pregnancy Complications, Infectious.
- Abortion, Spontaneous, Adolescent, Adult, Critical Illness, Disease Outbreaks, Female, Humans, Influenza A Virus, H1N1 Subtype, Intensive Care Units, Pregnancy, Premature Birth, Respiration, Artificial.
Abstract
BACKGROUND
During the influenza pandemic of spring 2009, Manitoba had a disproportionate number of pregnant women who became critically ill. Information about these cases will be useful to help us understand the potential impact of future outbreaks and review critical illness in pregnancy.
METHODS
We describe the clinical details of six critically ill pregnant women with pandemic H1N1 2009 influenza virus admitted to two ICUs in Manitoba between March 1 and August 31, 2009.
RESULTS
Thirty adult pregnant women tested positive for pandemic H1N1 2009 virus in Manitoba. Six women were admitted to the ICU. The time from onset of symptoms to life-threatening deterioration was on average five days. Most patients presented with worsening fever and cough and had H1N1-positive contacts. Five of six patients (83%) were Aboriginal. Four of six cases occurred in the third trimester. These patients frequently required non-conventional ventilatory support such as high frequency ventilation or extracorporeal membrane oxygenation (ECMO). All patients received oseltamivir. Two patients died while in the ICU. Three of six patients had adverse perinatal outcomes, and there was one spontaneous abortion and one early preterm delivery.
CONCLUSION
Pandemic H1N1 2009 influenza virus has the potential to cause severe illness in pregnant patients. Those patients requiring ICU admission for respiratory support have a high risk for poor fetal and neonatal outcome. The experience of this cohort underscores the appropriateness of public health measures directed at prevention and early treatment of H1N1 infection in pregnancy.
DOI: 10.1016/S1701-2163(16)34497-8
PubMed: 20500952
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.</title><author><name sortKey="Oluyomi Obi, Titilayo" sort="Oluyomi Obi, Titilayo" uniqKey="Oluyomi Obi T" first="Titilayo" last="Oluyomi-Obi">Titilayo Oluyomi-Obi</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Avery, Lisa" sort="Avery, Lisa" uniqKey="Avery L" first="Lisa" last="Avery">Lisa Avery</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB; Centre for Global Pubic Health, Department of Community Health Sciences, University of Manitoba, Winnipeg MB; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Schneider, Carol" sort="Schneider, Carol" uniqKey="Schneider C" first="Carol" last="Schneider">Carol Schneider</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Lapinsky, Stephen" sort="Lapinsky, Stephen" uniqKey="Lapinsky S" first="Stephen" last="Lapinsky">Stephen Lapinsky</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Toronto, Toronto ON.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Menticoglou, Savas" sort="Menticoglou, Savas" uniqKey="Menticoglou S" first="Savas" last="Menticoglou">Savas Menticoglou</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Zarychanski, Ryan" sort="Zarychanski, Ryan" uniqKey="Zarychanski R" first="Ryan" last="Zarychanski">Ryan Zarychanski</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB; Department of Haematology and Medical Oncology, Cancer Care Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20500952</idno><idno type="pmid">20500952</idno><idno type="doi">10.1016/S1701-2163(16)34497-8</idno><idno type="wicri:Area/Main/Corpus">000637</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000637</idno><idno type="wicri:Area/Main/Curation">000637</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000637</idno><idno type="wicri:Area/Main/Exploration">000637</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.</title><author><name sortKey="Oluyomi Obi, Titilayo" sort="Oluyomi Obi, Titilayo" uniqKey="Oluyomi Obi T" first="Titilayo" last="Oluyomi-Obi">Titilayo Oluyomi-Obi</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Avery, Lisa" sort="Avery, Lisa" uniqKey="Avery L" first="Lisa" last="Avery">Lisa Avery</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB; Centre for Global Pubic Health, Department of Community Health Sciences, University of Manitoba, Winnipeg MB; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Schneider, Carol" sort="Schneider, Carol" uniqKey="Schneider C" first="Carol" last="Schneider">Carol Schneider</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Lapinsky, Stephen" sort="Lapinsky, Stephen" uniqKey="Lapinsky S" first="Stephen" last="Lapinsky">Stephen Lapinsky</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Toronto, Toronto ON.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Menticoglou, Savas" sort="Menticoglou, Savas" uniqKey="Menticoglou S" first="Savas" last="Menticoglou">Savas Menticoglou</name><affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Zarychanski, Ryan" sort="Zarychanski, Ryan" uniqKey="Zarychanski R" first="Ryan" last="Zarychanski">Ryan Zarychanski</name><affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB; Department of Haematology and Medical Oncology, Cancer Care Manitoba, Winnipeg MB.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author></analytic><series><title level="j">Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</title><idno type="ISSN">1701-2163</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abortion, Spontaneous</term><term>Adolescent</term><term>Adult</term><term>Antiviral Agents (therapeutic use)</term><term>Critical Illness</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (complications)</term><term>Influenza, Human (therapy)</term><term>Intensive Care Units</term><term>Manitoba</term><term>Oseltamivir (therapeutic use)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (therapy)</term><term>Premature Birth</term><term>Respiration, Artificial</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Antiviraux (usage thérapeutique)</term><term>Avortement spontané</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Femelle</term><term>Flambées de maladies</term><term>Grippe humaine ()</term><term>Grossesse</term><term>Humains</term><term>Maladie grave</term><term>Manitoba</term><term>Naissance prématurée</term><term>Oséltamivir (usage thérapeutique)</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Unités de soins intensifs</term><term>Ventilation artificielle</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Oseltamivir</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Manitoba</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Abortion, Spontaneous</term><term>Adolescent</term><term>Adult</term><term>Critical Illness</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Intensive Care Units</term><term>Pregnancy</term><term>Premature Birth</term><term>Respiration, Artificial</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Avortement spontané</term><term>Complications de la grossesse et maladies infectieuses</term><term>Femelle</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Maladie grave</term><term>Manitoba</term><term>Naissance prématurée</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Unités de soins intensifs</term><term>Ventilation artificielle</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>During the influenza pandemic of spring 2009, Manitoba had a disproportionate number of pregnant women who became critically ill. Information about these cases will be useful to help us understand the potential impact of future outbreaks and review critical illness in pregnancy.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We describe the clinical details of six critically ill pregnant women with pandemic H1N1 2009 influenza virus admitted to two ICUs in Manitoba between March 1 and August 31, 2009.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Thirty adult pregnant women tested positive for pandemic H1N1 2009 virus in Manitoba. Six women were admitted to the ICU. The time from onset of symptoms to life-threatening deterioration was on average five days. Most patients presented with worsening fever and cough and had H1N1-positive contacts. Five of six patients (83%) were Aboriginal. Four of six cases occurred in the third trimester. These patients frequently required non-conventional ventilatory support such as high frequency ventilation or extracorporeal membrane oxygenation (ECMO). All patients received oseltamivir. Two patients died while in the ICU. Three of six patients had adverse perinatal outcomes, and there was one spontaneous abortion and one early preterm delivery.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Pandemic H1N1 2009 influenza virus has the potential to cause severe illness in pregnant patients. Those patients requiring ICU admission for respiratory support have a high risk for poor fetal and neonatal outcome. The experience of this cohort underscores the appropriateness of public health measures directed at prevention and early treatment of H1N1 infection in pregnancy.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20500952</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1701-2163</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>5</Issue><PubDate><Year>2010</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</Title><ISOAbbreviation>J Obstet Gynaecol Can</ISOAbbreviation></Journal><ArticleTitle>Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.</ArticleTitle><Pagination><MedlinePgn>443-447</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1701-2163(16)34497-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1701-2163(16)34497-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During the influenza pandemic of spring 2009, Manitoba had a disproportionate number of pregnant women who became critically ill. Information about these cases will be useful to help us understand the potential impact of future outbreaks and review critical illness in pregnancy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We describe the clinical details of six critically ill pregnant women with pandemic H1N1 2009 influenza virus admitted to two ICUs in Manitoba between March 1 and August 31, 2009.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty adult pregnant women tested positive for pandemic H1N1 2009 virus in Manitoba. Six women were admitted to the ICU. The time from onset of symptoms to life-threatening deterioration was on average five days. Most patients presented with worsening fever and cough and had H1N1-positive contacts. Five of six patients (83%) were Aboriginal. Four of six cases occurred in the third trimester. These patients frequently required non-conventional ventilatory support such as high frequency ventilation or extracorporeal membrane oxygenation (ECMO). All patients received oseltamivir. Two patients died while in the ICU. Three of six patients had adverse perinatal outcomes, and there was one spontaneous abortion and one early preterm delivery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pandemic H1N1 2009 influenza virus has the potential to cause severe illness in pregnant patients. Those patients requiring ICU admission for respiratory support have a high risk for poor fetal and neonatal outcome. The experience of this cohort underscores the appropriateness of public health measures directed at prevention and early treatment of H1N1 infection in pregnancy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oluyomi-Obi</LastName><ForeName>Titilayo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avery</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB; Centre for Global Pubic Health, Department of Community Health Sciences, University of Manitoba, Winnipeg MB; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapinsky</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Toronto, Toronto ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menticoglou</LastName><ForeName>Savas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg MB; Department of Haematology and Medical Oncology, Cancer Care Manitoba, Winnipeg MB.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Obstet Gynaecol Can</MedlineTA><NlmUniqueID>101126664</NlmUniqueID><ISSNLinking>1701-2163</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000022" MajorTopicYN="N">Abortion, Spontaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008350" MajorTopicYN="N" Type="Geographic">Manitoba</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20500952</ArticleId><ArticleId IdType="pii">S1701-2163(16)34497-8</ArticleId><ArticleId IdType="doi">10.1016/S1701-2163(16)34497-8</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Manitoba</li><li>Ontario</li></region><settlement><li>Toronto</li><li>Winnipeg</li></settlement><orgName><li>Université de Toronto</li><li>Université du Manitoba</li></orgName></list><tree><country name="Canada"><region name="Manitoba"><name sortKey="Oluyomi Obi, Titilayo" sort="Oluyomi Obi, Titilayo" uniqKey="Oluyomi Obi T" first="Titilayo" last="Oluyomi-Obi">Titilayo Oluyomi-Obi</name></region><name sortKey="Avery, Lisa" sort="Avery, Lisa" uniqKey="Avery L" first="Lisa" last="Avery">Lisa Avery</name><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name><name sortKey="Lapinsky, Stephen" sort="Lapinsky, Stephen" uniqKey="Lapinsky S" first="Stephen" last="Lapinsky">Stephen Lapinsky</name><name sortKey="Menticoglou, Savas" sort="Menticoglou, Savas" uniqKey="Menticoglou S" first="Savas" last="Menticoglou">Savas Menticoglou</name><name sortKey="Schneider, Carol" sort="Schneider, Carol" uniqKey="Schneider C" first="Carol" last="Schneider">Carol Schneider</name><name sortKey="Zarychanski, Ryan" sort="Zarychanski, Ryan" uniqKey="Zarychanski R" first="Ryan" last="Zarychanski">Ryan Zarychanski</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000591 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000591 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20500952
|texte= Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20500952" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |